Abby Lee Miller is spilling all to us about her lawsuit against Cedars-Sinai Marina Hospital -- recalling how it was only ...

An agent that may fulfill these requirements is the glycan-binding protein Galectin-9 (Gal-9). Indeed, treatment with Gal-9 reduced total cell counts and cell viability of various B cell NHL cell ...

In the autumn of 2022, Freddie Cole was diagnosed with stage 4 Burkitts lymphoma, a rare cancer of both the bone marrow and ...

Burkitt's lymphoma is the second commonest histological subtype of HIV-related lymphoma. The HIV-related BL resembles sporadic BL in that only 30% are EBV-positive and the characteristic c-myc ...

CHICAGO — In this video, Paolo F. Caimi, MD, MBA, staff physician at Cleveland Clinic, discusses the phase 2/3 WaveLINE-003 trial of patients with relapsed/refractory diffuse B-cell lymphoma ...

ASTANA – The innovative Kazakh pharmaceutical development Sovetonko has been valued at $160 million by international ...

CHICAGO — In this video, Ian W. Flinn, MD, PhD, discusses the phase 2 MorningSun study evaluating fixed-duration subcutaneous mosunetuzumab in patients with previously untreated, high-tumor ...

Incyte Lymphoma Treatment Gets FDA Approval Published: June 18, 2025, 4:12 p.m. ET Share Resize ...

More information: Xubin Li et al, Large B cell lymphoma microenvironment archetype profiles, Cancer Cell (2025). DOI: 10.1016/j.ccell.2025.06.002 ...